KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Other Non-Current Liabilities (2016 - 2023)

Historic Other Non-Current Liabilities for Palvella Therapeutics (PVLA) over the last 9 years, with Q4 2023 value amounting to $1.0 million.

  • Palvella Therapeutics' Other Non-Current Liabilities changed N/A to $1.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Palvella Therapeutics reported Other Non-Current Liabilities of $1.0 million as of Q4 2023.
  • Over the past 5 years, Palvella Therapeutics' Other Non-Current Liabilities peaked at $12.3 million during Q2 2019, and registered a low of $6000.0 during Q4 2020.
  • Its 3-year average for Other Non-Current Liabilities is $5.1 million, with a median of $1.0 million in 2023.
  • Data for Palvella Therapeutics' Other Non-Current Liabilities shows a peak YoY increase of 3765625.0% (in 2019) and a maximum YoY decrease of 2702.7% (in 2019) over the last 5 years.
  • Quarter analysis of 3 years shows Palvella Therapeutics' Other Non-Current Liabilities stood at $12.1 million in 2019, then crashed by 99.95% to $6000.0 in 2020, then skyrocketed by 16800.0% to $1.0 million in 2023.
  • Its Other Non-Current Liabilities was $1.0 million in Q4 2023, compared to $6000.0 in Q4 2020 and $12.1 million in Q3 2019.